1.
Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research
Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validations
2.7.
Assumptions
and Limitations
3.
Executive
Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Malaria Vaccine Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Vaccine Type (Pre-Erythrocytic, Erythrocytic,
Multi-antigen, Others)
5.2.2.
By Route of Administration (Intramuscular,
Subcutaneous, Intradermal, Others)
5.2.3.
By Region
5.2.4. By
Company (2022)
5.3.
Product Map
5.3.1.
By Vaccine Type
5.3.2.
By Route of Administration
5.3.3.
By Region
6. North America Malaria
Vaccine Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1.
By Vaccine Type
6.2.2. By
Route of Administration
6.2.3.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Malaria Vaccine Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Vaccine Type
6.3.1.2.2.
By Route of Administration
6.3.2.
Canada Malaria Vaccine Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Vaccine Type
6.3.2.2.2.
By Route of Administration
6.3.3.
Mexico Malaria Vaccine Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Vaccine Type
6.3.3.2.2.
By Route of Administration
7. Europe Malaria
Vaccine Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By
Vaccine Type
7.2.2.
By Route of Administration
7.2.3. By
Country
7.3.
Europe: Country Analysis
7.3.1.
France Malaria Vaccine Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Vaccine Type
7.3.1.2.2.
By Route of Administration
7.3.2.
Germany Malaria Vaccine Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Vaccine Type
7.3.2.2.2.
By Route of Administration
7.3.3.
United Kingdom Malaria Vaccine Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Vaccine Type
7.3.3.2.2.
By Route of Administration
7.3.4.
Italy Malaria Vaccine Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Vaccine Type
7.3.4.2.2.
By Route of Administration
7.3.5.
Spain Malaria Vaccine Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Vaccine Type
7.3.5.2.2.
By Route of Administration
8. Asia-Pacific Malaria
Vaccine Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Vaccine Type
8.2.2. By
Route of Administration
8.2.3.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
India Malaria Vaccine Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Vaccine Type
8.3.1.2.2.
By Route of Administration
8.3.2.
Japan Malaria Vaccine Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Vaccine Type
8.3.2.2.2.
By Route of Administration
8.3.3.
South Korea Malaria Vaccine Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Vaccine Type
8.3.3.2.2.
By Route of Administration
8.3.4.
Australia Malaria Vaccine Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Vaccine Type
8.3.4.2.2.
By Route of Administration
8.3.5.
Indonesia Malaria Vaccine Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Vaccine Type
8.3.5.2.2.
By Route of Administration
8.3.6.
Vietnam Malaria Vaccine Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Vaccine Type
8.3.6.2.2.
By Route of Administration
8.3.7.
Myanmar Malaria Vaccine Market Outlook
8.3.7.1.
Market Size & Forecast
8.3.7.1.1.
By Value
8.3.7.2.
Market Share & Forecast
8.3.7.2.1.
By Vaccine Type
8.3.7.2.2.
By Route of Administration
9. South America Malaria
Vaccine Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By
Vaccine Type
9.2.2.
By Route of Administration
9.2.3. By
Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Malaria Vaccine Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Vaccine Type
9.3.1.2.2.
By Route of Administration
9.3.2.
Colombia Malaria Vaccine Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Vaccine Type
9.3.2.2.2.
By Route of Administration
10. Middle East and
Africa Malaria Vaccine Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Vaccine Type
10.2.2. By
Route of Administration
10.2.3.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Malaria Vaccine Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Vaccine Type
10.3.1.2.2.
By Route of Administration
10.3.2.
Saudi Arabia Malaria Vaccine Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Vaccine Type
10.3.2.2.2.
By Route of Administration
10.3.3.
UAE Malaria Vaccine Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Vaccine Type
10.3.3.2.2.
By Route of Administration
10.3.4.
Egypt Malaria Vaccine Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Vaccine Type
10.3.4.2.2.
By Route of Administration
10.3.5.
Turkey Malaria Vaccine Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Vaccine Type
10.3.5.2.2.
By Route of Administration
10.3.6.
Nigeria Malaria Vaccine Market Outlook
10.3.6.1.
Market Size & Forecast
10.3.6.1.1.
By Value
10.3.6.2.
Market Share & Forecast
10.3.6.2.1.
By Vaccine Type
10.3.6.2.2.
By Route of Administration
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13. Global
Malaria Vaccine Market: SWOT Analysis
14. Porter’s
Five Forces Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Products
15.
Competitive Landscape
15.1.
Business Overview
15.2.
Product Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1.
GlaxoSmithKline, Plc.
15.5.2.
Novartis AG
15.5.3.
Takeda Pharmaceutical Company
15.5.4.
Sanaria Inc.
15.5.5.
Merck & Co.
15.5.6.
Johnson & Johnson
15.5.7.
Pfizer Inc.
15.5.8.
Serum Institute of India Private Limited
15.5.9.
Bharat Biotech International Limited
15.5.10.
Moderna Inc
16. Strategic Recommendations